Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ITGB3 contributors: mct - updated : 27-06-2017
HGNC name integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
HGNC id 6156
ASSOCIATED DISORDERS
corresponding disease(s) GT3
related resource Glanzmann Thrombasthenia Database
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --low  
in human hepatocellular carcinoma cells (Wu 2009)
constitutional     --low  
significantly reduced ITGB3 expression compared to controls, in recurrent pregnancy loss
constitutional     --over  
ITGA2B/ITGB3 is significantly higher in atopic myelitis (AM) patients than in controls as well as in females compared with males
constitutional germinal mutation     gain of function
activating mutations in ITGA2B and ITGB3 represent the etiology of a subset of congenital macrothrombocytopenias
Susceptibility
  • in association with PAI1 in susceptibility to myocardial infarction in Finnish population (see PAI1)
  • to cardiovascular disease
  • to neonatal autoimmune thrombocytopenia, post transfusion
  • to autism
  • Variant & Polymorphism SNP
  • 98 C>T in susceptibility to preeclampsia
  • Leu 33 associated with lower serotonin levels and with autism
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancerdigestiveliver
    reconstitution of ITGB3 in hepatocellular carcinoma may be a potential therapeutic approach to inhibit aggressive growth of liver cancer
    neurologyneurodegenerativealzheimer
    ITGA2B/ITGB3 complex activation could be a putative prognostic biomarker for the rate of cognitive decline and a potential new treatment target in Alzheimer patients
    cancermetastases 
    ITGB3 inhibitors are a potential therapeutic approach for blocking tumor transition to a bone destructive phenotype
    ANIMAL & CELL MODELS